genglob magazine


magazine by for generics, medicines and alternative treatments like ayurveda and traditional chinese

breast cancer treatment breakthroughs

Targeting Breast Tumors with SeedsOctober is officially tagged “Breast Cancer Awareness Month”. Of recent, there have been a lot of medical breakthroughs in the detection and treatment of Breast Cancer. Scientists have identified more accurate tools for screening younger women who are more likely to get the most dangerous forms and new strategies have also been developed for the treatment of newly diagnosed pregnant women.  Advanced research has led to the development of better, less toxic drugs to guard against recurrences. Read the rest of this entry »


Iressa (gefitinib) Improves Progression-free Survival over Standard Chemotherapy

how gefitinib works

Iressa (gefitinib) Improves Progression-free Survival over Standard Chemotherapy in Patients with NSCLC with EGFR Mutations. Read the rest of this entry »


Breast Cancer also targets men

breast cancer in manHélio de Carvalho knows all too well that breast cancer isn’t only a women’s illness.The Brazilian immigrant, 52, not only lived with the disease, but survived due to early detection.”I found it during a game with my ex-wife. I made her do self-exams and she told me I would have to do it too. That’s precisely when we noticed a lump on me. I thought it was nothing, but the doctor detected cancer,” Carvalho said. Read the rest of this entry »


Promising Novel Treatment For Human Cancer – Chrysanthemum Indicum Extract

Chrysanthemum Indicum ExtractA series of studies have demonstrated that Chrysanthemum indicum possesses antimicrobial, antiinflammatory, immunomodulatory, and neuroprotective effects. Recently, much attention has been devoted to the anticancer activity of Chrysanthemum indicum, especially in hepatocellular carcinoma (HCC). However, its anticancer mechanism of action is still not clear and needs further investigation. Read the rest of this entry »


Biocon to launch Abraxene in India

Biocon Limited, in alliance with the US-based Abraxis Bio Science, today announced the launch of Abraxane, an oncotheraputic drug for treatment of breast cancer, in India. The drug could be administered if combination therapy for metastatic disease failed or there was relapse within six months of adjuvant chemotherapy. The drug has been approved by the Drug Controller General of India in October 2007. Read the rest of this entry »